Anacor Pharmaceuticals Inc Stock
Equities
US0324201013
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing | RE |
2016 | Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel | RE |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Chief Tech/Sci/R&D Officer | 77 | 04-01-31 | |
Director/Board Member | - | 16-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Bryan Supran
BRD | Director/Board Member | - | 16-06-23 |
Director/Board Member | - | 16-06-23 |
1st Jan change | Capi. | |
---|---|---|
+0.44% | 42.86B | |
+12.32% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.83% | 25.15B | |
-23.42% | 18.63B | |
+28.08% | 12.37B | |
-3.52% | 11.92B | |
+6.64% | 11.21B |
- Stock Market
- Equities
- Stock